Skip to main content
OpenTrials

Clinical trial condition

Neurofibroma

Explore clinical trials studying Neurofibroma. Study availability and eligibility vary by location and protocol.

235 public trials 39 recruiting studies
Refine in advanced search Browse all conditions

Neurofibroma trial results

Completed

SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

NCT03433183

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fibrosarcoma, Genetic Diseases, Inborn, +22 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • National Cancer Institute Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

NCT04283669

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations
  • The University of Alabama at Birmingham (Site 700) Birmingham, Alabama, United States
  • Univ of California @ Los Angeles (Site 325) Los Angeles, California, United States
  • Children's National Medical Center (Site 775) Washington D.C., District of Columbia, United States
  • Children's HealthCare of Atlanta (Site 950) Atlanta, Georgia, United States
View all 15 locations
View Trial Details
Completed

NFX-179 Topical Gel Treatment for Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF)

NCT05005845

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cutaneous Neurofibroma, Genetic Diseases, Inborn, +14 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Northwest Arkansas Clinical Trials Center, PLLC Rogers, Arkansas, United States
  • Center for Dermatology Clinical Research, Inc. Fremont, California, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 23 locations
View Trial Details

Related conditions